Dean Clift

2.6k total citations · 1 hit paper
21 papers, 1.7k citations indexed

About

Dean Clift is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Dean Clift has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cell Biology and 6 papers in Immunology. Recurrent topics in Dean Clift's work include Microtubule and mitosis dynamics (6 papers), Protein Degradation and Inhibitors (6 papers) and Ubiquitin and proteasome pathways (6 papers). Dean Clift is often cited by papers focused on Microtubule and mitosis dynamics (6 papers), Protein Degradation and Inhibitors (6 papers) and Ubiquitin and proteasome pathways (6 papers). Dean Clift collaborates with scholars based in United Kingdom, Germany and United States. Dean Clift's co-authors include Melina Schuh, Leo C. James, William A. McEwan, Larisa I. Labzin, Vera Konieczny, Binyam Mogessie, Adèle L. Marston, Chun So, Marina Vaysburd and Adrian L. Oblak and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Dean Clift

20 papers receiving 1.7k citations

Hit Papers

A Method for the Acute and Rapid Degradation of Endogenou... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean Clift United Kingdom 17 1.1k 481 330 290 202 21 1.7k
Daniel Cimbora United States 21 1.4k 1.2× 421 0.9× 78 0.2× 307 1.1× 267 1.3× 36 2.2k
Tracy Keller United States 9 1.3k 1.2× 360 0.7× 78 0.2× 322 1.1× 126 0.6× 11 2.0k
Xavier Cayla France 26 1.1k 1.0× 322 0.7× 204 0.6× 163 0.6× 116 0.6× 48 1.5k
Michael A. Hadders Netherlands 16 736 0.6× 384 0.8× 93 0.3× 188 0.6× 74 0.4× 20 1.1k
Christopher J. Thorpe United Kingdom 21 1.3k 1.1× 185 0.4× 187 0.6× 501 1.7× 198 1.0× 38 2.2k
Peter I. Duncan Switzerland 16 1.5k 1.3× 521 1.1× 97 0.3× 142 0.5× 197 1.0× 19 1.8k
Heimo Riedel United States 22 1.2k 1.1× 182 0.4× 130 0.4× 125 0.4× 230 1.1× 55 1.8k
Blandine Geny France 24 1.4k 1.2× 609 1.3× 133 0.4× 427 1.5× 165 0.8× 55 2.1k
Edyta Marcon Canada 22 1.2k 1.0× 175 0.4× 102 0.3× 103 0.4× 228 1.1× 41 1.5k
Minoru Tada Japan 19 757 0.7× 169 0.4× 238 0.7× 295 1.0× 61 0.3× 78 1.5k

Countries citing papers authored by Dean Clift

Since Specialization
Citations

This map shows the geographic impact of Dean Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Clift more than expected).

Fields of papers citing papers by Dean Clift

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Clift. The network helps show where Dean Clift may publish in the future.

Co-authorship network of co-authors of Dean Clift

This figure shows the co-authorship network connecting the top 25 collaborators of Dean Clift. A scholar is included among the top collaborators of Dean Clift based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean Clift. Dean Clift is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lupták, Jakub, Dean Clift, Aamir S. Mukadam, et al.. (2025). State-selective small molecule degraders that preferentially remove aggregates and oligomers. Nature Communications. 16(1). 10486–10486.
2.
Leventhal, Shanna, Dean Clift, Kimberly Meade‐White, et al.. (2024). Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21. Nature Communications. 15(1). 9236–9236. 6 indexed citations
3.
Kiss, L., Jakub Lupták, Claire F. Dickson, et al.. (2023). Trim-Away ubiquitinates and degrades lysine-less and N-terminally acetylated substrates. Nature Communications. 14(1). 2160–2160. 20 indexed citations
4.
Fletcher, Alice, Dean Clift, Sergio Martínez Cuesta, et al.. (2023). A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation. Nature Communications. 14(1). 7093–7093. 23 indexed citations
5.
Lupták, Jakub, Donna L. Mallery, Aminu S. Jahun, et al.. (2022). TRIM7 Restricts Coxsackievirus and Norovirus Infection by Detecting the C-Terminal Glutamine Generated by 3C Protease Processing. Viruses. 14(8). 1610–1610. 15 indexed citations
6.
Su, Xue Bessie, Menglu Wang, Olga O. Nerusheva, et al.. (2021). SUMOylation stabilizes sister kinetochore biorientation to allow timely anaphase. The Journal of Cell Biology. 220(7). 11 indexed citations
7.
Kiss, L., Dean Clift, Nadine Renner, David Neuhaus, & Leo C. James. (2021). RING domains act as both substrate and enzyme in a catalytic arrangement to drive self-anchored ubiquitination. Nature Communications. 12(1). 1220–1220. 40 indexed citations
8.
Zeng, Jingwei, Aamir S. Mukadam, Mariana Osswald, et al.. (2021). Target-induced clustering activates Trim-Away of pathogens and proteins. Nature Structural & Molecular Biology. 28(3). 278–289. 68 indexed citations
9.
Albecka, Anna, Dean Clift, Marina Vaysburd, et al.. (2021). A functional assay for serum detection of antibodies against SARS‐CoV‐2 nucleoprotein. The EMBO Journal. 40(17). e108588–e108588. 18 indexed citations
10.
So, Chun, et al.. (2019). A liquid-like spindle domain promotes acentrosomal spindle assembly in mammalian oocytes. Science. 364(6447). 123 indexed citations
11.
Castro‐Dopico, Tomas, Thomas W. Dennison, John R. Ferdinand, et al.. (2019). Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis. Immunity. 50(4). 1099–1114.e10. 146 indexed citations
12.
Bottermann, Maria, Stian Foss, Sarah Caddy, et al.. (2019). Complement C4 Prevents Viral Infection through Capsid Inactivation. Cell Host & Microbe. 25(4). 617–629.e7. 52 indexed citations
13.
Labzin, Larisa I., Maria Bottermann, Stian Foss, et al.. (2019). Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection. The EMBO Journal. 38(21). e101365–e101365. 33 indexed citations
14.
Clift, Dean, Chun So, William A. McEwan, Leo C. James, & Melina Schuh. (2018). Acute and rapid degradation of endogenous proteins by Trim-Away. Nature Protocols. 13(10). 2149–2175. 117 indexed citations
15.
Clift, Dean, William A. McEwan, Larisa I. Labzin, et al.. (2017). A Method for the Acute and Rapid Degradation of Endogenous Proteins. Cell. 171(7). 1692–1706.e18. 372 indexed citations breakdown →
16.
McEwan, William A., Benjamin Falcon, Marina Vaysburd, et al.. (2017). Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation. Proceedings of the National Academy of Sciences. 114(3). 574–579. 134 indexed citations
17.
Clift, Dean & Melina Schuh. (2015). A three-step MTOC fragmentation mechanism facilitates bipolar spindle assembly in mouse oocytes. Nature Communications. 6(1). 7217–7217. 136 indexed citations
18.
Clift, Dean & Melina Schuh. (2013). Restarting life: fertilization and the transition from meiosis to mitosis. Nature Reviews Molecular Cell Biology. 14(9). 549–562. 204 indexed citations
19.
Clift, Dean & Adèle L. Marston. (2011). The Role of Shugoshin in Meiotic Chromosome Segregation. Cytogenetic and Genome Research. 133(2-4). 234–242. 44 indexed citations
20.
Clift, Dean, et al.. (2009). Shugoshin prevents cohesin cleavage by PP2ACdc55-dependent inhibition of separase. Genes & Development. 23(6). 766–780. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026